<DOC>
	<DOCNO>NCT00858559</DOCNO>
	<brief_summary>Patients implantable cardioverter defibrillator ( ICDs ) undergo regular device follow-up every 3 month , verify proper ICD function . However , many follow-ups uneventful , reveal relevant change relate implanted device patient 's diagnostic therapeutic status . For time economic reason , long follow-up interval frequently use although accord recommendation . This may increase delay detection relevant change disease deviation optimal ICD therapy individual patient . In new ICDs , essential parameter reflect safety appropriateness ICD therapy ( threshold , impedance , intracardiac electrogram , etc . ) transmit via Home Monitoring daily basis , internet platform accessible attend physician . In present study , investigator evaluate safety efficacy 12-month follow-up interval ICDs Home Monitoring capability , compare conventional 3-month follow-up scheme .</brief_summary>
	<brief_title>Follow-up Patients With Implantable Cardioverter Defibrillators Home Monitoring ( ANVITE )</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>Indication singlechamber implantable cardioverterdefibrillator ( ICD ) Contraindication ICD Indication dualchamber ICD cardiac resynchronization therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Implantable cardioverter defibrillator</keyword>
	<keyword>Remote monitoring</keyword>
	<keyword>Follow-up</keyword>
</DOC>